NFKB1 and neoplasm: NF-κB activation in myeloid cells typically enhances inflammation in the tumor microenvironment by increasing the secretion of pro-inflammatory cytokines such as TNF-α and IL-6, which eventually leads to rapid proliferation of tumor cells [72] and is responsible for inducible nitric oxide synthase (iNOS) activation to increase nitric oxide (NO).